Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LifeScience PLUS is a medical device company specializing in the development and commercialization of advanced hemostatic products for wound care and surgical applications. The company's flagship product line, BloodSTOP and BloodSTOP iX, utilizes a proprietary technology based on water-soluble, etherified sodium carboxymethyl cellulose. When in contact with blood, the material transforms into a biocompatible gel that seals the wound and accelerates the natural coagulation process. These products are designed for use in diverse settings, ranging from hospital surgical suites and trauma centers to consumer first aid. LifeScience PLUS focuses on providing fast-acting, non-irritating, and cost-effective solutions for hemorrhage control across global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeScience PLUS.